0 items USD 0.00Search
Your search for "globaldata community acquired infections global clinical trials review h1 2019" gave back 83405 results.
Summary Publisher estimates that the Tigecycline market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of...
Catalog:
HYR
April 2021
Price: USD 2,000.00
Summary The Tigecycline market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year...
Catalog:
HYR
February 2021
Price: USD 2,000.00
Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person with little contact with the healthcare...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Clinical trial patient recruitment companies use a range of methods, from digital advertising to community partnerships, to find the right patients...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Clinical trial patient recruitment companies use a range of methods, from digital advertising to community partnerships, to find the right patients...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Clinical trial patient recruitment companies use a range of methods, from digital advertising to community partnerships, to find the right patients...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
The Global Intravascular Catheters market is accounted for $3.84 billion in 2017 and is expected to reach $11.08 billion by 2026 growing at a CAGR of...
Catalog:
Stratistics MRC
January 2019
Price: USD 4,150.00
Summary HeyReport estimates that the Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market size will grow from xxx...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Summary HeyReport estimates that the Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market size will grow from xxx...
Catalog:
HYR
January 2021
Price: USD 2,000.00
Healthcare associated infections which mainly includes hospital or community acquired infections are persisting factor in each and every healthcare...
Catalog:
IQ4I
September 2016
Price: USD 4,950.00
The global Community Acquired Bacterial Pneumonia(CABP) Therapeutics market size is projected to grow from US$ 4644.7 million in 2022 to US$ 6755.7...
Catalog:
LPI
April 2023
Price: USD 3,660.00
The global Community Acquired Bacterial Pneumonia(CABP) Therapeutics market size was valued at USD 4885.5 million in 2022 and is forecast to a...
Catalog:
GIR
May 2023
Price: USD 3,480.00
The global Hospital-acquired Urinary Tract Infection Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person with little contact with the healthcare...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Community Acquired Bacterial Pneumonia(CABP) Therapeutics market size is expected to reach $ 6907.4 million by 2029, rising at a market...
Catalog:
GIR
May 2023
Price: USD 4,480.00
